Kura Oncology, Inc.
KURA
$8.58
-$0.15-1.72%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -321.50% | -36.23% | -30.07% | -15.96% | 55.09% |
| Total Depreciation and Amortization | 97.55% | -21.15% | 10.89% | 2.99% | -4.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 71.13% | 82.87% | -8.81% | -0.95% | 29.28% |
| Change in Net Operating Assets | -33.47% | -376.50% | 951.15% | -307.81% | 7,505.98% |
| Cash from Operations | -56.43% | -85.61% | 32.34% | -47.26% | 884.46% |
| Capital Expenditure | -523.92% | -- | -9,012.50% | -247.62% | -2,225.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 34.16% | 112.00% | 39.87% | -6.16% | -324.07% |
| Cash from Investing | 31.97% | 106.36% | 36.54% | -6.37% | -325.04% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 40.82% | -100.00% | -83.06% | -99.90% | 16.64% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 40.82% | -100.00% | -83.06% | -99.90% | 16.64% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -69.25% | 210.43% | 734.35% | -4,235.46% | 1,939.89% |